Please login to the form below

Not currently logged in
Email:
Password:

Duchenne muscular distrophy

This page shows the latest Duchenne muscular distrophy news and features for those working in and with pharma, biotech and healthcare.

NICE backs PTC's muscular dystrophy drug Translarna

NICE backs PTC's muscular dystrophy drug Translarna

Duchenne muscular dystrophy (DMD) patients and their families have welcomed a decision by NICE making PTC Therapeutics' Translarna available on the NHS. ... The Muscular Dystrophy UK charity described the decision as 'history in the making', and welcomed

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Thrive Agency

We are a specialist health communication agency creating powerful and trusted content. If you’re looking for a partner to help...

Latest intelligence

Virtual care – negotiating barriers to adoption offers glimpses of an exciting future
Digital tools and innovative healthcare promise to address pressing healthcare issues if they can satisfy concerns over access, security and affordability...
Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
...
New Playbook Alert: Virtual Patient Engagement
...